Ocugen Reports $1.95 Million Revenue, $3.6 Million Net Loss in Q3
Ocugen reported $19.7 million in operating expenses and a net loss per share of $0.01. It had $84.6 million in cash, cash equivalents, restricted cash and short-term investments; the supplied runway statement is truncated.
Ocugen reported third-quarter 2026 revenue of $1.95 million and a net loss of $3.6 million. Operating expenses were $19.7 million, and net loss per share was $0.01. The company reported $84.6 million in cash, cash equivalents, restricted cash and short-term investments, with runway expected into 20…